The Hong Kong government is paying the majority of the costs directly associated with managing type 2 diabetes mellitus

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.538, 2007-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recurrent Pyogenic Vertebral Osteomyelitis Associated with Type 2 Diabetes Mellitus

By Isobe Z Utsugi T Ohyama Y Miyazaki A Ito H Okuno S Uchiyama T Ohno T Arai M Tomono S Kurabayashi M

The Journal of International Medical Research, Vol. 29, Iss. 5, 2001-09 ,pp. : 445-450

Field House Publishing

Access to resources Recommend Favorite

Reductions in Individual Work Productivity Associated with Type 2 Diabetes Mellitus

By Lavigne J.E.

PharmacoEconomics, Vol. 21, Iss. 15, 2003-01 ,pp. : 1123-1134

Adis International

Access to resources Recommend Favorite

Bodyweight Changes Associated with Antihyperglycaemic Agents in Type 2 Diabetes Mellitus

By Hermansen Kjeld Mortensen Lene S.

Drug Safety, Vol. 30, Iss. 12, 2007-01 ,pp. : 1127-1142

Adis International

Access to resources Recommend Favorite

Linagliptin: In Type 2 Diabetes Mellitus

By Scott Lesley J.

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 611-624

Adis International

Access to resources Recommend Favorite

The prevention of type 2 diabetes mellitus

By Davies Melanie J.

Clinical Medicine, Vol. 3, Iss. 5, 2003-09 ,pp. : 470-474

Royal College Of Physicians

Access to resources Recommend Favorite